• Wondering whether Brown-Forman's share price still reflects what the business might be worth, or if the market has moved on faster than the fundamentals.
• The stock last closed at US$24.76, with returns that include a 4.5% decline over the past week, a 0.4% gain over the last month and declines of 5.3% year to date, 22.9% over 1 year, 59.2% over 3 years and 63.6% over 5 years.
• These longer term share price declines have kept Brown-Forman on investors' radars, as they reassess what a fair price could look like today. That reassessment is especially relevant for a well established beverages business, where sentiment can shift as markets weigh brand strength against what they are willing to pay.
• Simply Wall St's valuation model gives Brown-Forman a 5 out of 6 valuation score. The rest of this article will break down the different ways to think about that valuation and then finish with a framework that can help you interpret these numbers more effectively.

Approach 1: Brown-Forman Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting the company’s future cash flows and then discounting those cash flows back to today’s value.

For Brown-Forman, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections. The latest twelve month Free Cash Flow is about $687.2 million. Analyst inputs and Simply Wall St extrapolations suggest annual Free Cash Flow figures in the range of roughly $667 million to $831.9 million over the next decade, with 2035 Free Cash Flow projected at $831.9 million and discounted to $418.7 million in today’s terms.

Adding up these discounted cash flows and a terminal value gives an estimated intrinsic value of $37.81 per share, compared with a recent share price of $24.76. On this basis, the DCF implies Brown-Forman trades at a 34.5% discount to that intrinsic estimate, which points to the stock being undervalued on this specific cash flow view.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Brown-Forman is undervalued by 34.5%. Track this in your watchlist or portfolio, or discover 47 more high quality undervalued stocks.

Approach 2: Brown-Forman Price vs Earnings

For a profitable company like Brown-Forman, the P/E ratio is a useful yardstick because it links what you pay for the stock to the earnings the business is already generating. Investors typically accept a higher P/E when they expect stronger growth or see lower risk, and a lower P/E when growth expectations are modest or risks feel higher.

Brown-Forman currently trades at a P/E of 14.07x. That sits below both the Beverage industry average P/E of 16.92x and the broader peer group average of 42.87x, which suggests the stock is priced more conservatively than many of its listed peers.

Simply Wall St’s Fair Ratio for Brown-Forman is 16.65x. This is a proprietary estimate of what a reasonable P/E could look like for this specific company, based on factors such as its earnings growth profile, industry, profit margins, market cap and risk characteristics. Because it is tailored to Brown-Forman, the Fair Ratio can be more informative than a simple comparison with peers or an industry average.

Comparing the current P/E of 14.07x with the Fair Ratio of 16.65x indicates that the stock is trading below that fair multiple on this metric.

Result: UNDERVALUED

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Upgrade Your Decision Making: Choose your Brown-Forman Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives give you a clear story that links your view of Brown-Forman's brands and risks to explicit forecasts for revenue, earnings and margins, then turns that into a Fair Value you can compare with the current share price. On Simply Wall St's Community page, Narratives are an easy tool used by millions of investors. They let you see, for example, one Brown-Forman Narrative that assumes earnings reach about US$885.9 million by 2029 and supports a Fair Value close to US$36.85, alongside another that assumes earnings around US$734.3 million and a Fair Value near US$21. Narratives then help you decide whether the stock looks attractively or expensively priced relative to your own Fair Value. They also update automatically as new news, earnings or analyst estimates are added, so the story and the numbers stay aligned over time.

For Brown-Forman, we will make it really easy for you with previews of two leading Brown-Forman Narratives:

Fair Value: US$36.85

Implied discount to this Fair Value versus the recent US$24.76 share price: about 32.8%.

Revenue growth assumption: 4.11% a year.

• Bullish analysts see Jack Daniel's line extensions, distribution changes and emerging market expansion as key supports for revenue and margin potential.
• The narrative assumes earnings reach about US$885.9 million by 2029 with profit margins close to current levels and a future P/E of 21.4x.
• Risks include health and moderation trends, concentration in the Jack Daniel's family, cost inflation, regulation and reliance on mature markets.

Fair Value: US$21.00

Implied premium to this Fair Value versus the recent US$24.76 share price: about 17.9%.

Revenue growth assumption: 0.47% a year.

• Bearish analysts focus on flat revenue expectations, thinner margins at about 18.5% and a lower future P/E of 14.7x by 2029.
• The narrative highlights headwinds from health awareness, regulation, intense competition and reliance on a small group of core brands.
• It also flags limited exposure to faster growing regions compared with some global peers and questions how much investors might be willing to pay if these trends persist.

Together with the DCF and P/E work earlier, these narratives provide a structured way to decide which assumptions feel closest to your view of Brown-Forman and whether the current share price lines up with that story.

Do you think there's more to the story for Brown-Forman? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.